Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 19, 2015BloodOpen Access

Genetic diminution of circulating prothrombin ameliorates multiorgan pathologies in sickle cell disease mice

View Full Paper
Ask AI
Bookmark
Share

Authors

PAParitha ArumugamLaboratoire d’immunologie intégrative du cancerEMEric S. MullinsCincinnati Children's Hospital Medical CenterSSShiva Kumar ShanmukhappaBapuji Institute of Engineering and Technology

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Arumugam et al. (2015) studied this question.

synapsesocial.com/papers/6a731c2ca790b8554aacb697https://doi.org/10.1182/blood-2015-01-625707
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Aspirin-Dipyridamole Prophylaxis of Sickle Cell Disease Pain Crises1980 · 70 citations
  2. 2Distribution of Obstructive Intimal Lesions and Their Cellular Phenotypes in Chronic Pulmonary Hypertension2000 · 266 citations
  3. 3Differential contribution of FXa and thrombin to vascular inflammation in a mouse model of sickle cell disease2014 · 109 citations
  4. 4Association of Coagulation Activation with Clinical Complications in Sickle Cell Disease2012 · 112 citations
  5. 5Heparin inhibits the flow adhesion of sickle red blood cells to P-selectin2002 · 123 citations